Ottobock IPO: Why Wall Street Is So Bullish on This New Stock
Автор: US Stock Stories
Загружено: 2025-11-19
Просмотров: 13
Ottobock has officially gone public in Frankfurt, marking Germany’s biggest IPO in more than a year.
But why is Wall Street so optimistic about this newly listed human-bionics company?
In this video, Emily breaks down the first analyst notes:
✔ Deutsche Bank: Buy
✔ Goldman Sachs: Buy — €100 target
✔ Jefferies: Buy — €84 target
✔ Kepler Cheuvreux: Buy — €86 target
✔ UBS: Neutral — €74 target
We explore Ottobock’s leadership in prosthetics, neuro-orthotics, exoskeletons, and its global patient-care network — plus revenue and EBITDA growth expectations through 2027–2030.
If you want to understand why analysts expect strong margin expansion, robust free cash flow growth, and long-term demand in human bionics, this video breaks it all down.
👉 For deeper premium research, early stock ideas, and exclusive weekly reports:
patreon.com/usstockstories
Доступные форматы для скачивания:
Скачать видео mp4
-
Информация по загрузке:
![[2025] Feeling Good Mix - English Deep House, Vocal House, Nu Disco | Emotional / Intimate Mood](https://ricktube.ru/thumbnail/cxLdtvzf2sI/mqdefault.jpg)
